Northeast Investment Management Has Lifted Its Position in Facebook (FB) as Share Price Rose; Lilly Endowment Has Trimmed Eli Lilly And Company (LLY) Position by $34.85 Million as Share Price Declined

December 14, 2017 - By Dolores Ford

Northeast Investment Management increased its stake in Facebook Inc (FB) by 4.78% based on its latest 2017Q2 regulatory filing with the SEC. Northeast Investment Management bought 9,730 shares as the company’s stock rose 10.88% with the market. The institutional investor held 213,197 shares of the technology company at the end of 2017Q2, valued at $32.19 million, up from 203,467 at the end of the previous reported quarter. Northeast Investment Management who had been investing in Facebook Inc for a number of months, seems to be bullish on the $518.11B market cap company. The stock increased 0.76% or $1.34 during the last trading session, reaching $178.3. About 14.62 million shares traded. Facebook, Inc. (NASDAQ:FB) has risen 26.75% since December 14, 2016 and is uptrending. It has outperformed by 10.05% the S&P500.

Lilly Endowment Inc decreased its stake in Eli Lilly And Company (LLY) by 0.34% based on its latest 2017Q2 regulatory filing with the SEC. Lilly Endowment Inc sold 425,000 shares as the company’s stock declined 3.22% while stock markets rallied. The institutional investor held 124.27M shares of the major pharmaceuticals company at the end of 2017Q2, valued at $10.23B, down from 124.69M at the end of the previous reported quarter. Lilly Endowment Inc who had been investing in Eli Lilly And Company for a number of months, seems to be less bullish one the $92.04B market cap company. The stock increased 1.36% or $1.18 during the last trading session, reaching $87.89. About 5.79M shares traded or 75.81% up from the average. Eli Lilly and Company (NYSE:LLY) has risen 4.70% since December 14, 2016 and is uptrending. It has underperformed by 12.00% the S&P500.

Northeast Investment Management, which manages about $1.26 billion and $1.10 billion US Long portfolio, decreased its stake in V.F. Corp (NYSE:VFC) by 20,210 shares to 7,534 shares, valued at $434,000 in 2017Q2, according to the filing. It also reduced its holding in Gilead Sciences Inc (NASDAQ:GILD) by 150,086 shares in the quarter, leaving it with 16,454 shares, and cut its stake in American Tower Corp Reit (NYSE:AMT).

More notable recent Facebook, Inc. (NASDAQ:FB) news were published by: Nasdaq.com which released: “Facebook Inc (FB) COB and CEO Mark Zuckerberg Sold $42.5 million of Shares” on November 30, 2017, also Investorplace.com with their article: “2018 Could Be the Year Facebook, Inc. Stock Becomes Just Another Issue” published on December 08, 2017, Investorplace.com published: “Facebook Inc Has Built Itself Into a Rock-Solid Fortress” on December 11, 2017. More interesting news about Facebook, Inc. (NASDAQ:FB) were released by: Investorplace.com and their article: “3 Reasons Facebook Inc Stock Is Still a Standout Value” published on December 13, 2017 as well as Investorplace.com‘s news article titled: “Facebook Inc Stock Is the Best Investment in Struggling Tech Sector” with publication date: December 05, 2017.

Since August 7, 2017, it had 0 insider purchases, and 33 insider sales for $919.61 million activity. 16,000 shares valued at $2.74 million were sold by Cox Christopher K on Thursday, September 7. Zuckerberg Mark sold $42.50M worth of Facebook, Inc. (NASDAQ:FB) on Monday, August 14. Shares for $6.57 million were sold by Schroepfer Michael Todd. Another trade for 750 shares valued at $130,184 was made by Stretch Colin on Tuesday, September 12. Another trade for 50,533 shares valued at $8.59 million was sold by FISCHER DAVID B.. 15,470 shares were sold by Wehner David M., worth $2.59M on Monday, August 21.

Among 53 analysts covering Facebook (NASDAQ:FB), 49 have Buy rating, 2 Sell and 2 Hold. Therefore 92% are positive. Facebook had 210 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, June 15 by Canaccord Genuity. Robert W. Baird maintained Facebook, Inc. (NASDAQ:FB) rating on Friday, September 1. Robert W. Baird has “Buy” rating and $185.0 target. The stock has “Buy” rating by Cantor Fitzgerald on Friday, July 21. The rating was maintained by Oppenheimer on Thursday, April 28 with “Outperform”. On Monday, August 10 the stock rating was initiated by Susquehanna with “Positive”. Suntrust Robinson maintained it with “Buy” rating and $135 target in Thursday, April 28 report. The rating was maintained by Piper Jaffray on Tuesday, August 18 with “Overweight”. The company was maintained on Thursday, November 2 by RBC Capital Markets. The stock has “Outperform” rating by Wedbush on Thursday, October 1. The firm has “Buy” rating given on Thursday, July 27 by Goldman Sachs.

Investors sentiment increased to 1.4 in Q2 2017. Its up 0.05, from 1.35 in 2017Q1. It is positive, as 48 investors sold FB shares while 553 reduced holdings. 159 funds opened positions while 684 raised stakes. 1.62 billion shares or 0.41% less from 1.63 billion shares in 2017Q1 were reported. Highvista Strategies Limited Liability Company, a Massachusetts-based fund reported 20,300 shares. Crystal Rock Cap Mgmt invested in 80,590 shares. Pictet State Bank Ltd reported 2.68% stake. Private Cap Inc accumulated 46,770 shares. Jacobus Wealth Mgmt holds 0.07% or 1,719 shares in its portfolio. Hanseatic Mngmt Inc holds 0.49% or 6,355 shares. Bourgeon Management Lc holds 0.29% in Facebook, Inc. (NASDAQ:FB) or 3,026 shares. United Services Automobile Association reported 2.98 million shares. New York-based Altfest L J & has invested 1.23% in Facebook, Inc. (NASDAQ:FB). Carnegie Capital Asset Management Limited Liability Company invested in 51,802 shares or 1.07% of the stock. Schaper Benz Wise Counsel Inc Wi owns 0.44% invested in Facebook, Inc. (NASDAQ:FB) for 17,990 shares. Moreover, Novare Mngmt Ltd Llc has 1.4% invested in Facebook, Inc. (NASDAQ:FB) for 41,286 shares. St Germain D J has invested 1.5% in Facebook, Inc. (NASDAQ:FB). 340,994 are held by Walleye Trading Lc. Copper Rock Capital Prtn Llc has invested 0.04% of its portfolio in Facebook, Inc. (NASDAQ:FB).

Analysts await Eli Lilly and Company (NYSE:LLY) to report earnings on January, 30. They expect $1.08 EPS, up 13.68% or $0.13 from last year’s $0.95 per share. LLY’s profit will be $1.13 billion for 20.34 P/E if the $1.08 EPS becomes a reality. After $1.05 actual EPS reported by Eli Lilly and Company for the previous quarter, Wall Street now forecasts 2.86% EPS growth.

Among 20 analysts covering Eli Lilly and Company (NYSE:LLY), 12 have Buy rating, 1 Sell and 7 Hold. Therefore 60% are positive. Eli Lilly and Company had 87 analyst reports since July 23, 2015 according to SRatingsIntel. Leerink Swann maintained it with “Outperform” rating and $90 target in Tuesday, October 13 report. The company was upgraded on Friday, December 16 by Morgan Stanley. The firm has “Overweight” rating by Barclays Capital given on Friday, April 7. The rating was upgraded by BMO Capital Markets on Monday, November 16 to “Outperform”. The firm has “Buy” rating given on Thursday, November 16 by Jefferies. Argus Research maintained it with “Buy” rating and $95 target in Tuesday, August 2 report. The stock has “Hold” rating by Societe Generale on Wednesday, April 6. Jefferies maintained the shares of LLY in report on Thursday, June 22 with “Buy” rating. The company was maintained on Friday, April 7 by Citigroup. The stock of Eli Lilly and Company (NYSE:LLY) has “Buy” rating given on Tuesday, October 3 by Cowen & Co.

More notable recent Eli Lilly and Company (NYSE:LLY) news were published by: Fool.com which released: “The Case for Eli Lilly and Co.” on November 27, 2017, also Marketwatch.com with their article: “Eli Lilly hikes dividend by 8%” published on December 11, 2017, Nasdaq.com published: “Dodge & Cox Buys Eli Lilly and Co, Micro Focus International PLC, Gilead …” on November 14, 2017. More interesting news about Eli Lilly and Company (NYSE:LLY) were released by: Streetinsider.com and their article: “Eli Lilly & Co. (LLY) Raises Quarterly Dividend 8.2% to $0.5625; 2.6% Yield” published on November 14, 2017 as well as Prnewswire.com‘s news article titled: “Kimberly Blackwell, MD, to become Vice President of Early Phase Development …” with publication date: December 11, 2017.

Since August 31, 2017, it had 0 insider purchases, and 4 insider sales for $64.67 million activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.